The rapid growth of biologics and advanced therapies is placing new demands on supply chains, exposing infrastructure ga...
Zydus Lifesciences and Sunshine Healthcare have announced the setting up of a strategic joint venture (JV) company &ndas...
CStone Pharmaceuticals, a China-based biopharmaceutical company, has entered into an exclusive commercialisation agreeme...
Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...
Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Ella Woger-Nie...
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with U.S.-based biotechnology company Nuve...
The Department of Health – Abu Dhabi and Biocom California have announced a strategic partnership to create a form...
Cancer drug discovery is entering a more disciplined era. Investors, partners, and clinicians are increasingly focused o...
After several years of volatility, biotechnology financing has returned—but under very different rules. Investors ...
As biotechnology enters an increasingly data-driven era, organisations are rethinking how discovery, clinical developmen...
Cell and gene therapies have transformed the treatment landscape for complex diseases, yet scaling these innovations bey...
As biologics become increasingly sophisticated and development timelines continue to shrink, the role of Contrac...
At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
What made the episode significant was not its novelty — antibiotic shortages have been recurring across Europe for...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with South Korea's Samil Pharmace...
Korea-based Dong-A ST has entered into an exclusive licensing agreement with Melbourne-based Arrotex Pharmaceuticals, fo...
